Invention Grant
- Patent Title: Regulatory macrophages for treating angiopathies
-
Application No.: US16647121Application Date: 2018-09-12
-
Publication No.: US11648266B2Publication Date: 2023-05-16
- Inventor: Fred Fändrich
- Applicant: Trizell GmbH
- Applicant Address: DE Hamburg
- Assignee: Trizell GmbH
- Current Assignee: Trizell GmbH
- Current Assignee Address: DE Hamburg
- Agency: Hovey Williams LLP
- Priority: EP 190982 2017.09.13
- International Application: PCT/EP2018/074663 2018.09.12
- International Announcement: WO2019/053091A 2019.03.21
- Date entered country: 2020-03-13
- Main IPC: A61K35/15
- IPC: A61K35/15 ; A61P17/02 ; A61K9/00
Abstract:
The present invention relates to the use of immunoregulatory macrophages for treating diseases that are associated with pathological changes of the blood vessels. The present invention particularly relates to the use of immunoregulatory macrophages for treating micro- and macroangiopathies of the lower limbs. The invention furthermore relates to the use of immunoregulatory macrophages for promoting tissue remodelling to facilitate wound healing. Pharmaceutical compositions for use in the recited treatments are also disclosed which comprise the immunoregulatory macrophages.
Public/Granted literature
- US20200276236A1 REGULATORY MACROPHAGES FOR TREATING ANGIOPATHIES Public/Granted day:2020-09-03
Information query
IPC分类:
